ZH:NYSEZhihu Inc. Analysis
Data as of 2026-09-19 - not real-time
$3.21
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $3.21, Zhihu Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 1.2%. RSI sits at 63.6, which reads as approaching overbought, and MACD momentum is bullish. Recent trading has carved out support near $2.56 and resistance around $3.24.
Valuation screens as fair: a P/E of 58.2 sits above the sector average of 15.3. The average analyst target implies 27.6% above today's level. Revenue is contracting at 3.7% on a -11.4% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 48.1%, a beta of 1.02 and a maximum drawdown of 51.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Valuation screens as fair: a P/E of 58.2 sits above the sector average of 15.3. The average analyst target implies 27.6% above today's level. Revenue is contracting at 3.7% on a -11.4% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 48.1%, a beta of 1.02 and a maximum drawdown of 51.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
BEIJING, China, Aug. 26, 2026 GLOBE NEWSWIRE -- Zhihu Inc. “Zhihu” or the “Company” NYSE: ZH; HKEX: 2390 , a...Zhihu Inc ZH narrows operating losses while expanding AI content assets and expert data solutions, despite a...Zhihu Inc. announced a RMB1.5 billion investment in an AI-focused partnership, pending shareholder a
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.25
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 58.2 versus sector average of 15.3
- Trading below the 200-day average of 3.25
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 58.2 versus sector average of 15.3
- Negative profit margin of -11.4%
- Analyst targets imply +27.6% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-3.70%
Profit Margin-11.39%
P/E Ratio58.2
ROE-7.64%
ROA-4.35%
Debt/Equity3.40
P/B Ratio0.4
Op. Cash Flow$-317707008
Free Cash Flow$-237268256
Industry P/E15.3
Technical Analysis
TrendBearish
RSI63.6
Support$2.56
Resistance$3.24
MA 20$2.91
MA 50$3.10
MA 200$3.25
MACDBullish
VolumeIncreasing
Fear & Greed Index94.98
Valuation
Target Price$4.10
Upside/Downside27.57%
GradeFair
TypeBlend
Risk Assessment
Beta1.02
Volatility48.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.